FindTrial
Sign In

treatment of leukorrhea by HASTIKARNAYADI YOG

PHARMACOTHERAPEUTIC & PHARMACOGN0STICAL STUDY OF HASTIKARNAYADI YOG (KALPIT YOG) IN THE MANAGEMENT OF SHWETAPRADARA (LEUCORRHOEA) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081959
Enrollment
100
Registered
2025-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N899- Noninflammatory disorder of vagina, unspecified

Interventions

None listed

Sponsors

SHEKHAWATI AYURVEDIC MEDICAL COLLEGE PILANI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.PATIENTS WITH WHITE DISCHARGE PER VAGINA AS A CARDINAL SYMPTOM. 2.ADULT FEMALE WHO ARE IN THE AGE GROUP OF 16 TO 45 YEARS. 3.PATIENTS WILLING TO PARTICIPATE IN THE TRIAL.

Exclusion criteria

Exclusion criteria: 1.PATIENTS AGE BELOW 16 YEAR AND ABOVE 45 YEARS. 2.PATIENTS AFTER MENOPAUSE. 3.PATIENTS HAVING ILLNESS SUCH AS CANDIDIASIS, CERVICAL EROSION, CERVICITIS, TUBERCULOSIS OR MALIGNANT LESIONS OF THE GENITAL TRACT. 4.HBSAG, VDRL, HIV POSITIVE PATIENTS. 5.PATIENTS HAVING OTHER SYSTEMIC ILLNESS LIKE, DIABETES MELLITUS, TUBERCULOSIS, HTN, JAUNDICE ETC. 6.PREGNANT AND LACTATING FEMALE 7.HB LESS THEN 7 GM/DL

Design outcomes

Primary

MeasureTime frame
DECREASE SECRATIONTimepoint: 1 MONTH—

Secondary

MeasureTime frame
NO SECREATIONTimepoint: 2 MONTH—

Countries

India

Contacts

Public ContactDR MEENAKSHI KUMAWAT

PGIA, DSRRAU, JODHPUR

drmanojarora2503@gmail.com7976965588

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026